Key Takeaways
- • Forbes' 2022 "30 Under 30" venture capital list identifies emerging fund managers and young investors in their twenties who are actively deploying capital across diverse sectors including cryptocurrency, biotech, and cancer research.
- • Young venture capitalists featured on the list are launching their own funds and securing partner roles at established firms, breaking traditional age barriers in the industry while backing innovative startups.
- • The cohort represents a new wave of investors focused on "societal progress" and supporting founders who can "turn ideas into business reality," with investment programs like the Damon Runyon initiative providing $50,000 initial capital to support early-stage company formation.
- • Selected investors span multiple investment tracks including emerging managers, incubation experts, and early-stage venture capitalists who are actively participating in startup funding and portfolio management.
Summary
Forbes' 2022 "30 Under 30" venture capital list showcases a new generation of investors, including notable figures such as Doherty (age 23) and Schlisserman (age 25), who represent the vanguard of early-career capital deployment in technology and innovative sectors. These young venture capitalists are not merely limited partners in established funds but are actively launching their own investment vehicles and securing meaningful roles at premier firms—accomplishments that mark a significant departure from traditional venture capital gatekeeping.
The featured investors demonstrate broad investment theses spanning high-growth technology, cryptocurrency markets, biotech innovation, and specialized healthcare solutions including cancer research. This diversification reflects both the evolving risk-return landscape and the interests of a younger generation of allocators who prioritize both financial returns and societal impact. Investment programs tied to this ecosystem, such as the Damon Runyon initiative, provide structured entry capital—$50,000 initial investments—to support alumni and emerging clinical investigators launching new ventures, demonstrating institutional commitment to democratizing entrepreneurship.
The cohort's strategic positioning reveals a dual mandate: backing builders and founders while simultaneously establishing themselves as fund managers and investment decision-makers. By combining roles as emerging managers, incubation experts, and venture partners, these investors are reshaping capital formation in technology and life sciences, creating pathways for innovation across sectors from decentralized finance and crypto infrastructure to precision medicine and cancer therapeutics. Their presence on the 30 Under 30 list reflects both individual achievement and the broader structural shift toward younger leadership in alternative asset management.
The featured investors demonstrate broad investment theses spanning high-growth technology, cryptocurrency markets, biotech innovation, and specialized healthcare solutions including cancer research. This diversification reflects both the evolving risk-return landscape and the interests of a younger generation of allocators who prioritize both financial returns and societal impact. Investment programs tied to this ecosystem, such as the Damon Runyon initiative, provide structured entry capital—$50,000 initial investments—to support alumni and emerging clinical investigators launching new ventures, demonstrating institutional commitment to democratizing entrepreneurship.
The cohort's strategic positioning reveals a dual mandate: backing builders and founders while simultaneously establishing themselves as fund managers and investment decision-makers. By combining roles as emerging managers, incubation experts, and venture partners, these investors are reshaping capital formation in technology and life sciences, creating pathways for innovation across sectors from decentralized finance and crypto infrastructure to precision medicine and cancer therapeutics. Their presence on the 30 Under 30 list reflects both individual achievement and the broader structural shift toward younger leadership in alternative asset management.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.